Literature DB >> 6770743

Vasodilator therapy for chronic heart failure.

K Chatterjee, W W Parmley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6770743     DOI： 10.1146/annurev.pa.20.040180.002355

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  9 in total

Review 1.  A hitch-hiker's guide to the galaxy of adrenoceptors.

Authors:  G M Lees
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18

2.  Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis.

Authors:  P Nony; J P Boissel; M Lievre; A Leizorovicz; M C Haugh; S Fareh; B de Breyne
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 3.  Vasodilators.

Authors:  T T Zsotér
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

4.  Vasodilators in heart failure.

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-13

5.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

6.  Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure.

Authors:  D R Glover; W A Littler
Journal:  Br Heart J       Date:  1987-02

7.  Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors:  D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal:  Br Heart J       Date:  1985-02

8.  The effects of dopexamine on the cardiovascular system of the dog.

Authors:  R A Brown; J B Farmer; J C Hall; R G Humphries; S E O'Connor; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

9.  Preserved left ventricular systolic function in clinical congestive heart failure.

Authors:  B H Lee; J H Kim; H K Lim; C K Lee
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.